
Wednesday,
("Character," the "Company" or the "Group")
Designers, developers, and international distributor of toys, games, and giftware
Trading Update
and
Non-Executive Director Appointment
Trading Update
As previously highlighted in our
Looking ahead, the indications in the lead up to the all-important Christmas 2025 trading period are positive, with the Group's ranges selling well. It is also pleasing to report that new additions to our catalogue have previewed well at the Toy Fair in
The Group is scheduled to publish its audited report and accounts for the financial year ended
Board Appointment
The Board is also pleased to announce the appointment of
Kevin has extensive experience in the banking and finance sectors, having spent four decades working for Barclays Bank in various senior leadership roles in the
Kevin is a non-executive director at
Previous non-executive director roles held by Kevin were with
Commenting on the appointment, Character's Chair,
"On behalf of the Board and all stakeholders I am delighted to welcome Kevin to the business. He brings additional capabilities and leadership experience gained in his executive and NED roles which will further strengthen the Board."
Additional information regarding
Full name: Age: 66 |
|
Current directorships/partnerships: |
Previous directorships/partnerships (last five years): |
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 as it forms part of domestic law of the
FTSE AIM All-share: symbol: CCT Market cap: Email: info@charactergroup.plc.uk |
Group website: www.thecharacter.com Product ranges can also be viewed at www.character-online.co.uk |
Enquiries to: Hamun Shah, Group Finance Director Office: +44 (0) 208 329 3377
|
||
|
||
Panmure Liberum (Nominated Adviser and Joint Broker) Tel: +44 (0) 20 7886 2500 |
||
|
||
Tel: +44 (0) 20 3328 5656 |
||
|
|
|
Tel: +44 (0) 7785 703523 Email: fiona@tooleystreet.com |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the